NAMPT (Nicotinamide Phosphoribosyltransferase) Inhibitors Markets, 2040 with Profiles of Antengene Therapeutics, Aqualung Therapeutics, Karyopharm Therapeutics, OncoTartis, & Onxeo
DUBLIN, Dec. 19, 2022 /PRNewswire/ -- The "NAMPT Inhibitors Market, Distribution by Type of Molecule, Therapeutic Area, Indication, Route of…